Frank e/acc for biotech(@BeFrankmit) 's Twitter Profileg
Frank e/acc for biotech

@BeFrankmit

MIT PostDoc building @openbiobank https://t.co/eE116b9xJS. CEO of BGI Innovation. cofounder of @descisino. Serial entrepreneur and veteran on biotech. @MIT

ID:15184250

linkhttps://www.linkedin.com/in/befrankmit/ calendar_today20-06-2008 20:51:31

598 Tweets

225 Followers

1,8K Following

Moderna(@moderna_tx) 's Twitter Profile Photo

We’re excited to announce our ongoing collaboration with OpenAI to co-innovate with a shared vision of AI’s immense potential in the future of business and healthcare. and collaborations like this will be a key component to our ability to scale and maximize our impact on

account_circle
Andrew Curran(@AndrewCurran_) 's Twitter Profile Photo

OpenAI and Moderna are announcing a partnership this morning, according to the WSJ. They plan to incorporate AI into their efforts to design 15 new products over the next five years. This is a test flight for deep Enterprise integration.

OpenAI and Moderna are announcing a partnership this morning, according to the WSJ. They plan to incorporate AI into their efforts to design 15 new products over the next five years. This is a test flight for deep Enterprise integration.
account_circle
Andrew Curran(@AndrewCurran_) 's Twitter Profile Photo

Scientists at Eli Lilly have been surprised by the novelty of AI-driven pharma design. During the Patel podcast, Dario said that the models already possess all the information needed for biological breakthroughs; the bottleneck is capabilities, and we are nearing a tipping point.

Scientists at Eli Lilly have been surprised by the novelty of AI-driven pharma design. During the Patel podcast, Dario said that the models already possess all the information needed for biological breakthroughs; the bottleneck is capabilities, and we are nearing a tipping point.
account_circle
John Cumbers(@johncumbers) 's Twitter Profile Photo

.Ginkgo Bioworks Bioworks, Inc. decided to open up some of its experimental services to the community in a royalty-free, IP-free manner. This is going to be a big deal for start-ups! Check out this exclusive interview with Jason Kelly from Kostas Vavitsas
synbiobeta.com/read/ginkgo-br…

.@Ginkgo Bioworks, Inc. decided to open up some of its experimental services to the community in a royalty-free, IP-free manner. This is going to be a big deal for start-ups! Check out this exclusive interview with @jrkelly from @konvavitsas:  synbiobeta.com/read/ginkgo-br…
account_circle
Raheel Hasan(@theraheelhasan) 's Twitter Profile Photo

This is a fantastic example of how well-run companies communicate and make decisions. In 2019, Microsoft's CTO realized his mistake in judging Google and OpenAI, its AI rivals, and informed their CEO, Satya Nadella. Microsoft then invests more than $10B in OpenAI. Microsoft is

account_circle
Vincent Weisser(@vincentweisser) 's Twitter Profile Photo

We're launching Fast Compute Grants to support ambitious open-source AI research.

Apply here: primeintellect.ai/blog/fast-comp…

We're launching Fast Compute Grants to support ambitious open-source AI research. Apply here: primeintellect.ai/blog/fast-comp…
account_circle
JJ(@JosephJacks_) 's Twitter Profile Photo

Spending $50-100 Billion to train Transformer-based AI that also costs many billions to inference for hundreds of millions of users, not to mention billions of users … is a dead end. Architectures need to radically evolve 👉🏼 Liquid AI

account_circle
David Li(@davidycli) 's Twitter Profile Photo

the argument for starting a biotech co early in your career:

* the critical rate limiting step for life sciences innovation is mgmt talent and not capital. Getting biotech experience early means you'll be cornering the mkt later in your career

* nothing prepares you for the

account_circle